Breast cancer, vaccine

Breast cancer vaccine update from Cleveland Clinic: ‘A new era’
A breast cancer vaccine could be closer to reality, according to Cleveland Clinic, as its researchers have announced some encouraging results. Researchers and doctors weigh in.
New vaccine shows promise for patients with aggressive breast cancer
An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.
A Clinical Trial Found an Effective Vaccine for Aggressive Breast Cancer
An experimental vaccine teaching patients’ immune systems to identify and attack cancer cells could help women diagnosed with triple-negative breast cancer.
Wash U vaccine trial shows promising data in preventing breast cancer recurrence
A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer. Siteman Cancer Center just released the results of a clinical trial showing a new vaccine that is preventing cancer from returning.
Neoantigen DNA vaccine shows promise against aggressive breast cancer in clinical trial
A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at Washington University School of Medicine in St.
Triple negative breast cancer vaccine shows promising results
New research suggests an experimental vaccine could provide new hope for women diagnosed with an aggressive, hard-to-treat form of breast cancer. This vaccine is effective against triple-negative breast cancer,
New vaccine shows potential in preventing recurrence of triple-negative breast cancer
A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.
Researchers announce updated findings in preventive breast cancer vaccine study
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
Cleveland Clinic announces updated findings in preventive breast cancer vaccine study
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
New vaccine shows promise in treating aggressive form of breast cancer
Breast cancer patients have been given fresh hope after a new vaccine showed "promise" in treating an aggressive form of the disease. The results came in a clinical trial involving American patients with triple-negative breast cancer who received an experimental jab designed to prevent the recurrence of tumors.
Breast cancer break through as new vaccine shows 'promise' in treating aggressive form
Researchers say the results mark the first time a vaccine - known as a neoantigen DNA vaccine - has shown such positive results in a clinical trial.
'Is It Ethical?': Netizens Divided After Scientist Treats Her Cancer Using Experimental Vaccine
Halassy self-administered an experimental treatment usually reserved for patients with advanced or resistant cancers.
Anixa Biosciences Reports Promising Phase 1 Vaccine Results
Anixa Biosciences ( (ANIX) ) has provided an announcement. Anixa Biosciences, in collaboration with Cleveland Clinic, unveiled promising ...